UK markets close in 6 hours 53 minutes

ResMed Inc. (RMD)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
212.27+1.92 (+0.91%)
At close: 04:00PM EDT
212.27 0.00 (0.00%)
After hours: 05:44PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 31.18B
Enterprise value 32.11B
Trailing P/E 32.66
Forward P/E 25.25
PEG ratio (5-yr expected) 1.87
Price/sales (ttm)6.83
Price/book (mrq)6.74
Enterprise value/revenue 7.01
Enterprise value/EBITDA 21.33

Trading information

Stock price history

Beta (5Y monthly) 0.69
52-week change 3-2.07%
S&P500 52-week change 325.69%
52-week high 3229.97
52-week low 3132.24
50-day moving average 3206.14
200-day moving average 3176.11

Share statistics

Avg vol (3-month) 31.04M
Avg vol (10-day) 3782.72k
Shares outstanding 5146.91M
Implied shares outstanding 6146.91M
Float 8145.56M
% held by insiders 10.77%
% held by institutions 158.24%
Shares short (15 May 2024) 410.21M
Short ratio (15 May 2024) 48.12
Short % of float (15 May 2024) 47.93%
Short % of shares outstanding (15 May 2024) 46.95%
Shares short (prior month 15 Apr 2024) 47.95M

Dividends & splits

Forward annual dividend rate 41.92
Forward annual dividend yield 40.90%
Trailing annual dividend rate 31.88
Trailing annual dividend yield 30.89%
5-year average dividend yield 40.86
Payout ratio 428.92%
Dividend date 313 Jun 2024
Ex-dividend date 408 May 2024
Last split factor 22:1
Last split date 331 Aug 2010

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2021
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 20.91%
Operating margin (ttm)31.29%

Management effectiveness

Return on assets (ttm)11.91%
Return on equity (ttm)22.39%

Income statement

Revenue (ttm)4.58B
Revenue per share (ttm)31.17
Quarterly revenue growth (yoy)7.20%
Gross profit (ttm)N/A
EBITDA 1.44B
Net income avi to common (ttm)958.38M
Diluted EPS (ttm)6.50
Quarterly earnings growth (yoy)29.20%

Balance sheet

Total cash (mrq)259.45M
Total cash per share (mrq)1.77
Total debt (mrq)1.17B
Total debt/equity (mrq)25.21%
Current ratio (mrq)3.04
Book value per share (mrq)31.52

Cash flow statement

Operating cash flow (ttm)1.2B
Levered free cash flow (ttm)955.85M